Acadian Asset Management LLC Cocrystal Pharma, Inc. Transaction History

Acadian Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$0.7 - $1.58 $131,197 - $296,131	-187,425 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$0.48 - $2.19 $83,780 - $382,249	174,543 Added 1354.94%	187,425 $133,000
Q4 2018 Feb 07, 2019	BUY	$1.6 - $3.68 $17,500 - $40,251	10,938 Added 562.65%	12,882 $46,000
Q3 2018 Oct 30, 2018	BUY	$2.3 - $4.95 $4,471 - $9,622	1,944 New	1,944 $5,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $17.6M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.